Discoid Lupus Erythematosus Whole Blood

About Discoid Lupus Erythematosus Whole Blood

Discoid Lupus Erythematosus Whole Blood for Cutaneous Autoimmune Research

Discoid lupus erythematosus (DLE) is the most common form of chronic cutaneous lupus erythematosus, producing well-demarcated, scaly, disc-shaped plaques that heal with scarring, dyspigmentation and, on the scalp, permanent alopecia. Sanguine collects fresh Discoid Lupus Erythematosus Whole Blood from IRB-consented donors with a physician-confirmed DLE diagnosis and ships same-day, preserving both the nucleated cell fraction and the fluid phase.

Autoimmune Mechanisms in Discoid Lupus Erythematosus

DLE is a localised autoimmune disease in which cytotoxic inflammation is directed at the dermal-epidermal junction. Unlike systemic lupus erythematosus, DLE is usually confined to the skin and its serology is comparatively quiet — which is precisely why cell-based and transcriptomic readouts from whole blood are more informative here than autoantibody titres alone.

  • The histological hallmark is a lichenoid interface dermatitis: CD4+ and CD8+ T cells accumulate at the dermal-epidermal junction and drive keratinocyte apoptosis, producing the characteristic scarring.
  • A type I interferon signature is a well-established feature of cutaneous lupus, with plasmacytoid dendritic cells and interferon-induced gene expression central to lesional and systemic biology.
  • Ultraviolet light is a recognised trigger, linking keratinocyte injury and nucleic acid release to downstream interferon-driven inflammation.
  • Antinuclear antibodies are frequently negative or present only at low titre in DLE, distinguishing it serologically from systemic lupus; a minority of patients later develop systemic disease, making cohort annotation important.
  • Whole blood supports interferon-stimulated gene signature scoring and peripheral transcriptomic profiling — the readouts most closely tied to current cutaneous lupus therapeutic mechanisms.
  • Retaining nucleated cells allows genomic DNA and RNA to be recovered from the same collection, and permits researchers to derive plasma or serum in-house where analyte assays are also planned.

Donor Stratification Available

  • Lesion distribution: localised (head and neck) vs generalised DLE
  • Scalp involvement with scarring alopecia
  • Presence or absence of concurrent systemic lupus erythematosus features
  • Antinuclear antibody status where documented
  • Treatment status: topical or intralesional corticosteroid, antimalarial (hydroxychloroquine), systemic immunosuppressant, biologic, or treatment-naive
  • Photosensitivity, smoking status and disease duration where documented
  • Matched healthy controls available

Product Features

  • Fresh whole blood from clinically diagnosed DLE donors
  • Custom anticoagulants and collection tubes available, including EDTA, heparin and RNA-stabilising formats
  • Same-day collection and shipment
  • Standard and custom volumes; volumes reported per lot
  • Research Use Only (RUO)

De-identified Donor Data

  • Physician-confirmed diagnosis, including lesion distribution where available
  • Demographics: age, sex assigned at birth, ethnicity
  • Relevant medical and treatment history
  • Concurrent autoimmune diagnoses and comorbidities where documented
  • Additional DLE-specific metadata available on request

Applications

  • Type I interferon signature scoring and interferon-stimulated gene expression analysis
  • Peripheral blood transcriptomic and single-cell profiling
  • Genomic DNA extraction for genotyping and sequencing in cutaneous lupus
  • Epigenetic and DNA methylation studies
  • Cutaneous versus systemic lupus comparative studies
  • Antimalarial and biologic therapy response research
  • Scarring and fibrosis biomarker discovery
  • Derivation of plasma or serum for complement and cytokine analyte work

Other Discoid Lupus Erythematosus Specimen Types

Compliance and Quality Assurance

  • IRB-approved protocols and electronic informed consent
  • 21 CFR Part 11-compliant e-signatures
  • HIPAA-compliant donor data handling
  • Documentation support available for regulatory review

Ordering & Customization

Discoid Lupus Erythematosus Whole Blood is available in standard and custom volumes. For pricing, current availability, international orders or documentation requirements, email learnmore@sanguinebio.com. To browse other disease-state options and live stock status across our whole blood inventory, visit our human whole blood page.

Applications

  • Hematology and clinical chemistry research
  • Plasma, serum, and PBMC isolation
  • Flow cytometry and biomarker studies
  • Drug-spike and ex vivo stimulation assays

Product Features

  • Research Use Only (RUO), human whole blood
  • Collected from screened, consented donors
  • Available in EDTA, sodium heparin, ACD, or citrate anticoagulants
  • Shipped fresh under temperature-controlled conditions
  • Drawn and shipped same day of collection
  • IRB-approved protocols with electronic informed consent

Donor Metadata

  • Verified diagnosis and clinical history
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Medication and treatment background when available

Compliance and Quality Assurance

  • IRB-approved collections and standardized procedures
  • 21 CFR Part 11-compliant e-consent system
  • HIPAA-compliant data management

Ordering & Customization

Human Whole Blood are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.

Whole Blood

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Discoid Lupus Erythematosus Whole Blood with normal donor samples for comparison

Healthy Whole Blood

Screened normal donors · Fresh · Starting at $350
View Inventory

Need a custom Whole Blood cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information